title: [The potentials of combined chemotherapy in disseminated ovarian cancer].
authors.forename: V A
authors.initials: VA
authors.lastname: Gorbunova
authors.forename: N I
authors.initials: NI
authors.lastname: Perevodchikova
authors.forename: V P
authors.initials: VP
authors.lastname: Kozachenko
authors.forename: V M
authors.initials: VM
authors.lastname: Ryzhakov
authors.forename: A F
authors.initials: AF
authors.lastname: Marenich
authors.forename: K I
authors.initials: KI
authors.lastname: Zhordania
mesh_terms: D006585:Altretamine / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality; D012074:Remission Induction
chemical_list: D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin; D006585:Altretamine
vernacular_title: Vozmozhnosti kombinirovannoĭ khimioterapii rasprostranennogo raka iaichnikov.